- Home
- ENZ vs KRON Comparison
ENZ vs KRON Comparison
Compare ENZ & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- KRON
- Stock Information
- Founded
- ENZ 1976
- KRON 2017
- Country
- ENZ United States
- KRON United States
- Employees
- ENZ N/A
- KRON N/A
- Industry
- ENZ Medical Specialities
- KRON Medicinal Chemicals and Botanical Products
- Sector
- ENZ Health Care
- KRON Health Care
- Exchange
- ENZ Nasdaq
- KRON Nasdaq
- Market Cap
- ENZ 56.4M
- KRON 60.3M
- IPO Year
- ENZ N/A
- KRON 2020
- Fundamental
- Price
- ENZ $0.70
- KRON $0.96
- Analyst Decision
- ENZ
- KRON Buy
- Analyst Count
- ENZ 0
- KRON 3
- Target Price
- ENZ N/A
- KRON $1.63
- AVG Volume (30 Days)
- ENZ 198.0K
- KRON 384.9K
- Earning Date
- ENZ 12-16-2024
- KRON 11-13-2024
- Dividend Yield
- ENZ 14.27%
- KRON N/A
- EPS Growth
- ENZ N/A
- KRON N/A
- EPS
- ENZ N/A
- KRON N/A
- Revenue
- ENZ $30,314,000.00
- KRON $9,864,000.00
- Revenue This Year
- ENZ N/A
- KRON $62.21
- Revenue Next Year
- ENZ N/A
- KRON N/A
- P/E Ratio
- ENZ N/A
- KRON N/A
- Revenue Growth
- ENZ 2.72
- KRON 146.48
- 52 Week Low
- ENZ $0.68
- KRON $0.69
- 52 Week High
- ENZ $1.50
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- ENZ 14.85
- KRON 49.73
- Support Level
- ENZ $1.00
- KRON $0.92
- Resistance Level
- ENZ $1.05
- KRON $1.03
- Average True Range (ATR)
- ENZ 0.06
- KRON 0.06
- MACD
- ENZ -0.02
- KRON -0.00
- Stochastic Oscillator
- ENZ 3.95
- KRON 32.13
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.